Indivior Pharmaceuticals, Inc. Common Stock (INDV) Stock Price

INDVStock
$35.97+48.77%52W
Market Cap$4.24B
P/E21.59x
PEG Ratio
Div yield
Beta0.58

INDV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-5.95%
Price vs S&P 500 (4W)-14.79%
VGM Score48.49
P/E Ratio (Annual)21.59x

INDV Earnings Surprise History

Q2 250.51est. 0.25
Q3 250.72est. 0.41
Q4 250.82est. 0.67
Q1 260.96est. 0.66
Q2 261.15est. 0.92

INDV Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.25
4.25
4.25

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
INDVIndivior Pharmaceuticals, Inc. Common Stock
CCC$35.97
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Indivior Pharmaceuticals, Inc. Common Stock

Indivior Pharmaceuticals specializes in treating opioid use disorder (OUD) through buprenorphine-based pharmaceutical products. Its primary revenue sources are Sublocade, an extended-release monthly injection, and Suboxone, a sublingual film combining buprenorphine and naloxone. The company addresses a significant therapeutic need in the management of opioid dependence as a chronic, treatable medical condition.